If you need more lookups,
subscriptions start at $34 USD/month.
Nan Li Location
Pennsylvania, United States
Nan Li Work
Senior Director, Global Market Access Immunology Rheum and Derm @ (September 2024 - Present)
Head of Value, Evidence and Access, Japan @ (February 2023 - October 2024)
Director, Global Market Access, Retina @ (March 2020 - February 2023)
Associate Director, Patient-Reported Outcome, Global Market Access @ (May 2018 - March 2020)
Health Economic Analyst and Manager and Associate Director , Global Market Access @ (October 2014 - April 2018)
Research Scientist @ (September 2012 - September 2014)
Research Associate @ (July 2009 - September 2012)
Intern, Department of International Service @ (November 2007 - June 2008)
Nan Li Education
Johns Hopkins Bloomberg School of Public Health
Ph.D. (Public Health)
Johns Hopkins Bloomberg School of Public Health
MHS (Biostatistics)
Peking University Health Science Center
Bachelor of Medicine (Bachelor of Surgery - MBBS, Medicine)
Nan Li Skills
Global Health
Epidemiology
SAS
Public Health
Data Analysis
Data Management
Clinical Research
Infectious Diseases
Literature Reviews
Stata
Health Economics
Research
Program Evaluation
Statistics
International Health
Gene Therapy
HEOR
Health Technology Assessment (HTA)
Market Access
New Business Development
Patient Reported Outcomes
Rare Diseases
Real World Data (RWD)
Real World Evedence
Strategic Planning
Value Propositions
Nan Li Summary
Nan Li, based in Pennsylvania, United States, is currently a Senior Director, Global Market Access Immunology Rheum and Derm at Johnson & Johnson. Nan Li brings experience from previous roles at Johnson & Johnson and The Janssen Pharmaceutical Companies of Johnson & Johnson. Nan Li holds a Ph.D. in Public Health @ Johns Hopkins Bloomberg School of Public Health. With a robust skill set that includes Global Health, Epidemiology, SAS, Public Health, Data Analysis and more. Nan Li has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Nan Li?
Find contact details for 700 million professionals.